Dynamic evaluation of clinical efficacy of fire needle of Lingnan on plaque psoriasis by dermoscopy

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006400

Enrollment

Unknown

Registered

2022-07-31

Start date

2022-07-31

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

Chinese medicine group:Oral Chinese medicine

Fireneedle group:Fireneedle

Caspotriol group:Caspotriol for external use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The age range of 18-60 years old; The area of skin lesion was less than 50% of body surface area No systemic treatment or topical use of glucocorticoid, retinoids, etc. Volunteer to accept the treatment plan designed by the subject, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Those who do not meet the inclusion criteria; A woman who is pregnant or preparing for pregnancy or lactation; Patients with serious organic diseases of heart, brain, blood vessel, liver, kidney or primary diseases of hematopoietic system, and patients with psychosis; Allergic constitution or to the treatment of drugs, methods allergic patients; Fear of acupuncture, refused to fire acupuncture treatment; scar physique.

Design outcomes

Primary

Measure	Time frame
Dermoscopy;PASI;TH1/TH2(14 elements);Serum iron, serum ferritin, serum total ferritin, serum transferrin saturation;	—

Secondary

Measure	Time frame
(DLQI);(GAD-7);LRFT;(PHQ-9);routine blood test;	—

Countries

China

Contacts

Public ContactLi Jingjing

lijingjing85@gzucm.edu.cn075529629333

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026